Other · Sep 2014
Review articlePublished 7 Jul 2016
Immunotherapy for Type 1 diabetes: past and future
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Type 1 diabetes is regarded as an autoimmune disease and, in accordance with this, trials using immune suppression and general or specific immune modifications have been carried out. Most trials have been successful in animals, but it has not been possible to reproduce these results in humans. Some effects have, however, been observed in subgroups of patients, but no drug has shown a general effectiveness. The side effects have been acceptable. The failure has been suggested to be due to insufficient doses, late start or the need for a combination of drugs. It could also simply be that this is an inappropriate way to attack the disease. It is therefore time for a new approach in the battle against Type 1 diabetes. The autoimmune findings could be an expression of defense and an effort to restore damaged b cells. More effort has to be put into a critical evaluation of environmental factors to find the very early agents promoting Type 1 diabetes.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2017
How did things get so bad? The past, present and future of diabetes type-2
Article · Nov 2012
Pediatric diabetes management:past, present and future
Article · 28 Oct 2024
Immunotherapy for Type 1 Diabetes: A New Frontier in Treatment
Conference abstract · 2016
Proinsulin peptide immunotherapy in new-onset type 1 diabetes is well tolerated and associated with a reduced daily insulin dose
More from this journal
The newest in Diabetes Management.
Article · 28 Oct 2025
Glucose control in older adults with diabetes following intra-articular and epidural triamcinolone acetonide injections
Article · 22 Jan 2025
Lipodystrophy with an uncommon clinical presentation in a patient with type 2 diabetes on insulin therapy
Article · 22 Jan 2025
Lipodystrophy with an uncommon clinical presentation in a patient with type 2 diabetes on insulin therapy
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDiabetes Management
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Mona Landin-Olsson & Charlotte Erlanson-Albertsson”
